A new complex rearrangement involving the ETV6, LOCII5548, and MNI genes in a case of acute myeloid leukemia

被引:13
作者
Belloni, E
Trubia, M
Mancini, M
Derme, V
Nanni, M
Lahortiga, I
Riccioni, R
Confalonieri, S
Lo-Coco, F
Di Fiore, PP
Pelicci, PG
机构
[1] Ist FIRC Oncol Mol, I-20139 Milan, Italy
[2] Ist Europeo Oncol, Milan, Italy
[3] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Sect Hematol, Rome, Italy
[4] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain
[5] Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, Rome, Italy
[6] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy
关键词
D O I
10.1002/gcc.20081
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A new complex rearrangement involving chromosome bands 5q13, 12p13, 22q11, and 3q12 was identified and characterized in a patient with acute myeloid leukemia. Fluorescence in situ hybridization showed the involvement of the ETV6 gene in 12p13. ETV6 primers were specifically designed for 3' and 5'-RACE-PCR experiments, which led to the identification of the other two rearranged genes. The derivative chromosome 5 harbored a fusion of the ETV6 sequence with that of the LOC115548 gene. The two genes were placed in opposite orientation and did not encode a fusion protein. On the derivative chromosome 12, ETV6 was fused to the MN1 gene on chromosome 22. Also in this case, the insertion, within the MN1 sequence, of a portion of chromosome 3 prevented the formation of a fusion protein. Finally, the derivative chromosome 22 contained the 3' portions of both LOC115548 and MN1, and no fusion transcript with coding potential could be predicted. In conclusion, all chromosome breakpoints led to the truncation of the three involved genes in the absence of predicted fusion proteins. This study lends further support to the hypothesis that gene disruption resulting in either loss of function or haploinsufficiency may be relevant in acute myeloid leukemia pathogenesis. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 29 条
  • [1] A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton
    Aspenstrom, P
    [J]. CURRENT BIOLOGY, 1997, 7 (07) : 479 - 487
  • [2] Genomic organization of TEL: The human ETS-variant gene 6
    Baens, M
    Peeters, P
    Guo, CY
    Aerssens, J
    Marynen, P
    [J]. GENOME RESEARCH, 1996, 6 (05): : 404 - 413
  • [3] Molecular cytogenetics of t(12;21)(p13;q22)
    Bernard, OA
    Romana, SP
    Poirel, H
    Berger, R
    [J]. LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 459 - &
  • [4] Fusion genes in leukemia: an emerging network
    Bohlander, SK
    [J]. CYTOGENETICS AND CELL GENETICS, 2000, 91 (1-4): : 52 - 56
  • [5] BUIJS A, 1995, ONCOGENE, V10, P1511
  • [6] The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity
    Buijs, A
    van Rompaey, L
    Molijn, AC
    Davis, JN
    Vertegaal, ACO
    Potter, MD
    Adams, C
    van Baal, S
    Zwarthoff, EC
    Roussel, MF
    Grosveld, GC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (24) : 9281 - 9293
  • [7] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [8] Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13)
    Cools, J
    Mentens, N
    Odero, MD
    Peeters, P
    Wlodarska, I
    Delforge, M
    Hagemeijer, A
    Marynen, P
    [J]. BLOOD, 2002, 99 (05) : 1776 - 1784
  • [9] DEPREZ RHL, 1995, ONCOGENE, V10, P1521
  • [10] Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia
    Fröhling, S
    Skelin, S
    Liebisch, C
    Scholl, C
    Schlenk, RF
    Döhner, H
    Döhner, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2480 - 2485